Hyloris Pharmaceuticals SA (EBR:HYL)
Belgium
· Delayed Price · Currency is EUR 6.00
-0.08 (-1.32%)
At close: Dec 5, 2025
Hyloris Pharmaceuticals Market Cap
Hyloris Pharmaceuticals has a market cap or net worth of €168.00 million as of December 5, 2025. Its market cap has increased by 6.76% in one year.
Market Cap
168.00M
Enterprise Value
150.53M
Revenue
8.46M
Ranking
n/a
PE Ratio
n/a
Stock Price
€6.00
Market Cap Chart
Since June 29, 2020, Hyloris Pharmaceuticals's market cap has decreased from 244.70M to 168.00M, a decrease of -31.34%. That is a compound annual growth rate of -6.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 168.00M | -8.26% |
| Dec 31, 2024 | 183.12M | -48.71% |
| Dec 29, 2023 | 357.00M | 14.84% |
| Dec 30, 2022 | 310.88M | -30.44% |
| Dec 31, 2021 | 446.90M | 82.11% |
| Dec 31, 2020 | 245.41M | 0.29% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| argenx SE | 47.19B |
| UCB SA | 47.02B |
| Financière de Tubize | 9.88B |
| Fagron NV | 1.53B |
| Ion Beam Applications | 328.37M |
| Nyxoah | 184.15M |
| Onward Medical | 183.21M |
| Sequana Medical NV | 42.65M |